Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology 

Slides:



Advertisements
Similar presentations
EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Advertisements

Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Volume 63, Issue 1, Pages (July 2015)
Volume 46, Issue 3, Pages (March 2007)
Kirsten Boonstra, Ulrich Beuers, Cyriel Y. Ponsioen 
Inflammasomes in liver diseases
Volume 61, Issue 4, Pages (October 2014)
Volume 67, Issue 2, Pages (August 2017)
Volume 50, Issue 4, Pages (April 2009)
Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: A systematic review  Christian Thoma, Christopher P. Day, Michael.
Volume 68, Issue 5, Pages (May 2018)
Julien Bissonnette, Dominique Valla, Pierre-Emmanuel Rautou 
Volume 61, Issue 6, Pages (December 2014)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis  Astrid Marot, Jean Henrion, Jean-François.
Volume 153, Issue 4, Pages (October 2017)
Hepatitis B and C virus-related carcinogenesis
Natural history of hepatitis B
Living donor liver transplantation: is the hype over?
Volume 69, Issue 2, Pages (August 2018)
Volume 44, Pages S19-S24 (January 2006)
The place of downstaging for hepatocellular carcinoma
Reply to: “Low free T3 levels are related to early mortality in patients with decompensated cirrhosis and acute-on chronic liver failure”  Rakhi Maiwall,
Volume 65, Issue 4, Pages (October 2016)
European Association for the Study of the Liver  Journal of Hepatology 
Volume 68, Issue 1, Pages (January 2018)
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study  Gyuri Kim, Suk-Yong Jang, Chung.
Trends in the management and burden of alcoholic liver disease
Volume 61, Issue 1, Pages S69-S78 (November 2014)
Why men are at higher risk for hepatocellular carcinoma?
Ming-Ling Chang, Yun-Fan Liaw  Journal of Hepatology 
Genomic risk of hepatitis C-related hepatocellular carcinoma
Autophagy in the liver Journal of Hepatology
Behzad Hajarizadeh, Jason Grebely, Gregory J. Dore 
EASL Clinical Practice Guidelines: Wilson’s disease
Roberto de Franchis, Aleksander Krag  Journal of Hepatology 
The changing role of beta-blocker therapy in patients with cirrhosis
Hepatitis B and C virus-related carcinogenesis
Volume 57, Issue 5, Pages (November 2012)
Volume 50, Issue 4, Pages (April 2009)
Antiviral therapy for chronic hepatitis B: Challenges in Hong Kong
Paul C. Adams, James C. Barton  Journal of Hepatology 
Volume 61, Issue 1, Pages S79-S90 (November 2014)
Volume 56, Issue 6, Pages (June 2012)
Chetana Lim, Chady Salloum, Daniel Azoulay
Immigration and viral hepatitis
Evolution of liver transplantation for hepatocellular carcinoma
Global burden of alcoholic liver diseases
HCV targeting of patients with cirrhosis
Role of desmoplasia in cholangiocarcinoma and hepatocellular carcinoma
Volume 63, Issue 1, Pages (July 2015)
Volume 51, Issue 2, Pages (August 2009)
Hepatitis C infection: A multi-faceted systemic disease with clinical, patient reported and economic consequences  Zobair M. Younossi, Aybike Birerdinc,
Hepatorenal syndrome, MELD score and liver transplantation: An evolving issue with relevant implications for clinical practice  Paolo Angeli, Pere Gines 
Volume 66, Issue 3, Pages (March 2017)
Volume 62, Issue 4, Pages (April 2015)
Integrating sorafenib into an algorithm for the management of post-transplant hepatocellular carcinoma recurrence  Christian Toso, Gilles Mentha, Pietro.
New trials and results in systemic treatment of HCC
Volume 126, Issue 4, Pages (April 2004)
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Genetics of hepatocellular carcinoma: The next generation
Outcomes in liver transplantation: Does sex matter?
Reversion of disease manifestations after HCV eradication
Presentation transcript:

Hepatitis B virus-related decompensated liver cirrhosis: Benefits of antiviral therapy  Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw  Journal of Hepatology  Volume 57, Issue 2, Pages 442-450 (August 2012) DOI: 10.1016/j.jhep.2012.02.033 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Natural history of hepatitis B virus (HBV)-related cirrhosis. /yr, per year. Journal of Hepatology 2012 57, 442-450DOI: (10.1016/j.jhep.2012.02.033) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Fig. 2 Management of patients with hepatitis B virus (HBV)-related decompensated liver disease. HCC, hepatocellular carcinoma; HRS, hepatorenal syndrome; SBP, spontaneous bacterial peritonitis. Journal of Hepatology 2012 57, 442-450DOI: (10.1016/j.jhep.2012.02.033) Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Journal of Hepatology 2012 57, 442-450DOI: (10. 1016/j. jhep. 2012. 02 Copyright © 2012 European Association for the Study of the Liver Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.